International Assets Investment Management LLC Acquires 615,891 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

International Assets Investment Management LLC raised its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10,227.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 621,913 shares of the company’s stock after acquiring an additional 615,891 shares during the period. International Assets Investment Management LLC’s holdings in GE HealthCare Technologies were worth $58,367,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Pathway Financial Advisers LLC acquired a new position in GE HealthCare Technologies during the first quarter valued at approximately $25,000. Fred Alger Management LLC bought a new position in shares of GE HealthCare Technologies during the second quarter worth $26,000. BNP Paribas acquired a new position in shares of GE HealthCare Technologies in the 1st quarter valued at $30,000. Elkhorn Partners Limited Partnership bought a new stake in shares of GE HealthCare Technologies in the 2nd quarter valued at $31,000. Finally, ORG Partners LLC raised its stake in GE HealthCare Technologies by 2,475.0% during the 2nd quarter. ORG Partners LLC now owns 412 shares of the company’s stock worth $32,000 after buying an additional 396 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $88.42 on Monday. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.82. The business has a 50-day moving average of $88.42 and a 200-day moving average of $83.41. The stock has a market capitalization of $40.36 billion, a price-to-earnings ratio of 25.85, a PEG ratio of 3.34 and a beta of 1.18. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The firm had revenue of $4.84 billion during the quarter, compared to the consensus estimate of $4.88 billion. During the same period last year, the company earned $0.92 earnings per share. The business’s revenue was up .5% compared to the same quarter last year. As a group, sell-side analysts predict that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.14%. The ex-dividend date of this dividend is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.51%.

Insider Buying and Selling at GE HealthCare Technologies

In other news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the sale, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at approximately $1,414,377.02. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.27% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and decreased their price objective for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. JPMorgan Chase & Co. initiated coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They set a “neutral” rating and a $90.00 target price for the company. Evercore ISI lifted their price target on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. Finally, BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a research report on Wednesday, September 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $94.23.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.